ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $909,404 | -0.2% | 33,501 | +13.1% | 0.00% | 0.0% |
| Q2 2023 | $911,201 | -7.0% | 29,628 | +9.0% | 0.00% | 0.0% |
| Q1 2023 | $979,460 | +67.2% | 27,187 | +83.4% | 0.00% | +100.0% |
| Q4 2022 | $585,949 | -39.8% | 14,822 | -38.9% | 0.00% | -50.0% |
| Q3 2022 | $974,000 | +46.5% | 24,278 | +47.4% | 0.00% | +100.0% |
| Q2 2022 | $665,000 | +136.7% | 16,473 | +96.3% | 0.00% | 0.0% |
| Q1 2022 | $281,000 | +2.9% | 8,392 | +4.7% | 0.00% | 0.0% |
| Q4 2021 | $273,000 | -19.5% | 8,013 | -31.3% | 0.00% | 0.0% |
| Q3 2021 | $339,000 | -93.4% | 11,663 | -90.8% | 0.00% | -90.9% |
| Q2 2021 | $5,150,000 | +24.7% | 126,418 | +35.5% | 0.01% | +10.0% |
| Q1 2021 | $4,130,000 | +1170.8% | 93,276 | +1445.8% | 0.01% | +900.0% |
| Q4 2020 | $325,000 | – | 6,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |